CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 18, 2022 · PDUFA decision

AMRX PDUFA decision: a positive outcome, +8.5%

On August 18, 2022, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +8.5% in the window around the event.

The move

$2.58
1d before
$2.80
Event day
$2.71
1d after
$2.53
5d after

Pre-catalyst setup

-2.7%
30-day run-up
7894%
30-day volatility